Abstract
The proto-oncoprotein c-Ets1 is a transcription factor essential for haematopoietic differentiation and angiogenesis, but it is also a key driver of carcinogenesis. Ets family members are regulated by autoinhibition, where internal domains fold to mask the DNA-binding domain (DBD). This study identifies a novel intramolecular interaction between the DBD and an N-terminal region of c-Ets1. Using GST pull-down and yeast two-hybrid assays, researchers mapped the interaction sites and compared c-Ets1 with its viral homologue, v-Ets. The findings reveal that this internal interaction is significantly stronger in v-Ets, providing a structural explanation for its aggressive DNA binding and role in tumorigenesis.
Introduction
Transcription factors like c-Ets1 act as master switches within the cell, but their activity must be precisely controlled. c-Ets1 employs a mechanism known as autoinhibition, where the protein essentially folds in on itself to prevent unnecessary DNA binding. While inhibitory domains at the N- and C-termini were previously known to be involved, the specific physical contact points mediating this self-regulation remained unmapped. This research aims to define these intramolecular interactions and explore how viral mutations in v-Ets disrupt this regulatory balance.
Methods
The study utilized a combination of biochemical and cellular assays to map the protein's internal architecture:
- GST Pull-down Assays: Used to detect physical interactions between tagged and immobilized protein fragments in vitro.
- Yeast Two-Hybrid System: Confirmed interactions within living yeast cells via reporter gene activation.
- Deletion Mapping: Systematically truncated protein constructs were used to pinpoint the exact amino acid sequences required for binding.
- In Vitro Translation: Radioactively labeled ($^{35}$S) fragments were produced for high-sensitivity detection of protein complexes.
Results
The Autoinhibitory Mechanism
A critical finding of the study is that the full-length c-Ets1 protein exists in an inhibited state that prevents internal domain interactions with external fragments. As shown in Figure 1, the N-terminal fragment (M36) readily interacts with fragments containing the DNA-binding domain (106 and 118). However, the full-length protein (M13) shows no such interaction, indicating that the C-terminal domain acts as a "brake" or shield that maintains the autoinhibited state in the cellular protein.
Mapping the Interaction Site
To identify the precise residues involved in this "internal handshake," the researchers tested various sub-fragments of the DNA-binding domain. The strongest interaction was localized to a 67-amino acid region (residues 395-462), which includes specific structural elements like $\beta$-strands and $\alpha$-helices.
Discussion
The study proposes a new model for c-Ets1 regulation. Upon DNA binding, the protein undergoes a structural shift that temporarily allows the N-terminal region to interact with the DBD, stabilizing the protein-DNA complex. In normal c-Ets1, the C-terminal domain eventually re-establishes the inhibited state, causing the complex to dissociate.
In the viral homologue v-Ets, mutations or truncations in the C-terminal domain remove this regulatory "brake." This leads to a constitutively strong N-terminal/DBD interaction, resulting in hyper-active DNA binding. This structural change likely contributes to the ability of v-Ets to drive uncontrolled cell proliferation and tumorigenesis in avian leukemia.
Conclusion
By characterizing the physical contact points of c-Ets1 autoinhibition, this research provides a structural explanation for the functional differences between cellular and viral Ets proteins. These insights into intramolecular regulation offer a clearer understanding of how viral hijacking of normal cellular machinery can lead to cancer.
Summary updated